Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/05/2026 | Q4 | $117.4M | -- | -- | $38.29 | -- |
| 10/30/2025 | Q3 | $116.9M | $128.7M | $8.42 | $31.27 | -$22.85 |
| 07/31/2025 | Q2 | $112.5M | $114.5M | $32.60 | $21.48 | $11.12 |
| 05/01/2025 | Q1 | $116.4M | $111.1M | -$16.49 | -$0.02 | -$16.46 |
| 02/05/2025 | Q4 | $122.7M | $120.7M | -$3.03 | $0.06 | -$3.09 |
| 10/30/2024 | Q3 | $121.5M | $116.1M | -$1.72 | -$0.02 | -$1.71 |
| 08/01/2024 | Q2 | $122M | $111.4M | -$0.57 | -$0.02 | -$0.55 |
| 04/29/2024 | Q1 | $121.4M | $115.2M | -$0.31 | -$0.01 | -$0.30 |
| 02/06/2024 | Q4 | $132.2M | $124.5M | $0.50 | $0.02 | $0.48 |
| 11/01/2023 | Q3 | -- | $129.5M | -$10.09 | -- | -- |
| 08/01/2023 | Q2 | -- | $120.4M | $1.52 | -- | -- |
| 05/01/2023 | Q1 | -- | $121.9M | $31.79 | -- | -- |
| 02/02/2023 | Q4 | -- | $132.6M | -$2.19 | -- | -- |
| 11/01/2022 | Q3 | -- | $125.4M | -$2.39 | -- | -- |
| 08/02/2022 | Q2 | -- | $122.1M | -$94.01 | -- | -- |
| 05/03/2022 | Q1 | -- | $119.3M | -$11.58 | -- | -- |
| 02/01/2022 | Q4 | -- | $134.5M | -$0.84 | -- | -- |
| 10/28/2021 | Q3 | -- | $128M | -$3.61 | -- | -- |
| 07/29/2021 | Q2 | -- | $125.4M | -$30.71 | -- | -- |
| 04/29/2021 | Q1 | -- | $122.9M | -$11.40 | -- | -- |
| 01/28/2021 | Q4 | -- | $131.3M | $0.03 | -- | -- |
| 10/27/2020 | Q3 | -- | $127.4M | -$1.48 | -- | -- |
| 07/28/2020 | Q2 | -- | $110.6M | $0.35 | -- | -- |
| 03/31/2020 | Q1 | -- | $111.4M | $0.07 | -- | -- |
| 12/31/2019 | Q4 | -- | $133.5M | $0.12 | -- | -- |
| 10/29/2019 | Q3 | -- | $119.7M | $0.09 | -- | -- |
| 07/30/2019 | Q2 | -- | $117.7M | $0.20 | -- | -- |
| 04/30/2019 | Q1 | -- | $115.4M | -$0.08 | -- | -- |
| 01/29/2019 | Q4 | -- | $131.9M | $0.03 | -- | -- |
| 10/25/2018 | Q3 | -- | $122.2M | $0.11 | -- | -- |
| 07/26/2018 | Q2 | -- | $120.6M | $0.04 | -- | -- |
| 04/26/2018 | Q1 | -- | $123M | $0.02 | -- | -- |
| 01/25/2018 | Q4 | -- | $136.4M | -$0.22 | -- | -- |
| 10/26/2017 | Q3 | -- | $126M | $0.16 | -- | -- |
| 07/27/2017 | Q2 | -- | $119.2M | $0.09 | -- | -- |
| 04/27/2017 | Q1 | -- | $122.2M | $0.13 | -- | -- |
| 01/31/2017 | Q4 | -- | $140.1M | $0.27 | -- | -- |
| 10/27/2016 | Q3 | -- | $129.9M | $0.23 | -- | -- |
| 07/28/2016 | Q2 | -- | $123.1M | $0.16 | -- | -- |
| 04/27/2016 | Q1 | -- | $119M | $0.12 | -- | -- |
| 01/27/2016 | Q4 | -- | $143.5M | $0.34 | -- | -- |
Strategy, Inc. reported $128.7M worth of top line sales in its most recent quarter.
Strategy, Inc. announced earnings per share of $8.42 which represents a miss of analyst forecast a $31.27 per share.
Strategy, Inc. reported $90.7M that represents $0.29 per share over the last quarter.
Strategy, Inc.'s earnings are forecast to decrease from -$6.06 per share to -$3.08 per share next year representing a decrease of -98.01%.
Strategy, Inc.'s next earnings date is February 5, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.